3 recruiting, 1 completed. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 3, Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow antisecretory factor: new trials by email Literature Review of antisecretory factor trials Research Report on antisecretory factor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma Salovum - Glioblastoma | Phase 2 | Recruiting | Peter Siesjö | 10 | 2024-10-07 | 2026-01-23 |
| Antisecretory Factor Glioblastoma Phase 2 Salovum, Placebo egg yolk powder - Glioblastoma | Phase 2 / Phase 3 | Recruiting | Peter Siesjö | 300 | 2024-01-15 | 2026-01-09 |
| Antisecretory Factor In Severe Traumatic Brain Injury Salovum, Placebo egg yolk powder - Traumatic Brain Injury | Phase 2 | Recruiting | Peter Siesjö | 20 | 2020-03-10 | 2026-01-21 |
| Antisecretory Factor in Primary Glioblastoma 1 Salovum - Glioblastoma, Cerebral Edema | Phase 1 / Phase 2 | Completed | Peter Siesjö | 8 | 2019-09-01 | 2021-04-28 |
Glioblastoma (3) · Brain Edema (2) · Brain Injuries, Traumatic (1)
Peter Siesjö (4)
Sweden (4)
Charlotte Edwardsson (1) · Erik Ehinger, MD (1)
PMID 36803465, PMID 39920739, PMID 40083039
2019 (1)